Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-007387
Filing Date
2025-11-17
Accepted
2025-11-17 16:17:20
Documents
6
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_111525.htm 6-K 5936
2 EXHIBIT 99.1 exh_991.htm EX-99.1 431778
3 EXHIBIT 99.2 exh_992.htm EX-99.2 251785
4 EXHIBIT 99.3 exh_993.htm EX-99.3 11491
5 EXHIBIT 99.4 exh_994.htm EX-99.4 11564
6 GRAPHIC logo.jpg GRAPHIC 16613
  Complete submission text file 0001171843-25-007387.txt   736609
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 251491268
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)